|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Accounts payable and accrued expenses | ||||
| Depreciation and amortization expense | ||||
| Interest expense | ||||
| Stock based compensation | ||||
| Gain on debt extinguishment | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable, net | ||||
| Allowance for credit losses | ||||
| Contract assets | ||||
| Other current assets | ||||
| Long-term assets | ||||
| Accounts payable | ||||
| Accrued payroll | ||||
| Other current liabilities | ||||
| Contract liabilities | ||||
| Operating lease right-of-use assets and lease liabilities | ||||
| Net cash used in operating activities | ||||
| Repayments of stockholder advances | ||||
| Proceeds from note payable - stockholder | ||||
| Cash Flows from Investing Activities: | ||||
| Purchases of property, plant and equipment | ||||
| Cash acquired in reverse acquisition | ||||
| Net cash used in investing activities | ||||
| Cash Flows from Financing Activities: | ||||
| Payment of finance lease liability | ||||
| Proceeds from Offering, net of Offering costs | ||||
| Proceeds from issuance of Series A Prime Preferred Stock | ||||
| Payment of share repurchase liability | ||||
| Proceeds from exercise of stock options | ||||
| Net cash provided by financing activities | ||||
| Net change in cash and cash equivalents | ||||
| Cash - beginning of year | ||||
| Cash - end of year | ||||
| Effect of exchange rate on cash and cash equivalents | ||||
| Cash and cash equivalents: | ||||
| Beginning of period | ||||
| End of period | ||||
| Supplemental schedule of non-cash investing and financing activities: | ||||
| Issuance of common stock in reverse acquisition | ||||
Loading...